Full text
PDF








Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ENGLEY F. B., Jr, SCOTT M. J. Studies on gastric mucin. III. The effect of gastric mucin on the antibacterial action of normal blood. Tex Rep Biol Med. 1954;12(2):236–249. [PubMed] [Google Scholar]
- ENGLEY F. B., Jr Studies on gastric mucin. I. In vivo and in vitro studies with Shigella dysenteriae. Tex Rep Biol Med. 1953;12(1):49–63. [PubMed] [Google Scholar]
- FIELD T. E., HOWARD J. G., WHITBY J. L. Studies on the rapid production of a non-specific type of immunity to Salmonella typhi infection in mice. J R Army Med Corps. 1955 Oct;101(4):324–334. [PubMed] [Google Scholar]
- HESTRIN S., SHILO M., FEINGOLD D. S., WOLMAN B. Promotion of peritoneal infection by intravenous levan. Br J Exp Pathol. 1954 Apr;35(2):112–117. [PMC free article] [PubMed] [Google Scholar]
- LAMBERT H. P., RICHLEY J. The action of mucin in promoting infections: the anticomplementary effect of mucin extracts and certain other substances. Br J Exp Pathol. 1952 Aug;33(4):327–339. [PMC free article] [PubMed] [Google Scholar]
- LANDY M., PILLEMER L. Elevation of properdin levels in mice following administration of bacterial lipopolysaccharides. J Exp Med. 1956 Jun 1;103(6):823–833. doi: 10.1084/jem.103.6.823. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LANDY M., PILLEMER L. Increased resistance to infection and accompanying alteration in properidin levels following administration of bacterial lipopolysaccharides. J Exp Med. 1956 Sep 1;104(3):383–409. doi: 10.1084/jem.104.3.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LANDY M., SHEAR M. J. Similarity of host responses elicited by polysaccharides of animal and plant origin and by bacterial endotoxins. J Exp Med. 1957 Jul 1;106(1):77–97. doi: 10.1084/jem.106.1.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Olitzki L. MUCIN AS A RESISTANCE-LOWERING SUBSTANCE. Bacteriol Rev. 1948 Jun;12(2):149–172. doi: 10.1128/br.12.2.149-172.1948. [DOI] [PMC free article] [PubMed] [Google Scholar]
- PILLEMER L., BLUM L., LEPOW I. H., ROSS O. A., TODD E. W., WARDLAW A. C. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science. 1954 Aug 20;120(3112):279–285. doi: 10.1126/science.120.3112.279. [DOI] [PubMed] [Google Scholar]
- PILLEMER L., BLUM L., LEPOW I. H., WURZ L., TODD E. W. The properdin system and immunity. III. The zymosan assay of properdin. J Exp Med. 1956 Jan 1;103(1):1–13. doi: 10.1084/jem.103.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- PILLEMER L., LANDY M., SHEAR M. J. The properdin system and immunity. VII. Alterations in properdin levels and resistance to infection in mice following the administration of tissue polysaccharides. J Exp Med. 1957 Jul 1;106(1):99–110. doi: 10.1084/jem.106.1.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- PILLEMER L., ROSS O. A. Alterations in serum properdin levels following injection of Zymosan. Science. 1955 May 20;121(3151):732–733. doi: 10.1126/science.121.3151.732. [DOI] [PubMed] [Google Scholar]
- PILLEMER L., SCHOENBERG M. D., BLUM L., WURZ L. Properdin system and immunity. II. Interaction of the properdin system with polysaccharides. Science. 1955 Sep 23;122(3169):545–549. doi: 10.1126/science.122.3169.545. [DOI] [PubMed] [Google Scholar]
- ROWLEY D. Rapidly induced changes in the level of non-specific immunity in laboratory animals. Br J Exp Pathol. 1956 Jun;37(3):223–234. [PMC free article] [PubMed] [Google Scholar]
- ROWLEY D. Stimulation of natural immunity to Escherichia coli infection: observations on mice. Lancet. 1955 Jan 29;268(6857):232–234. doi: 10.1016/s0140-6736(55)90163-x. [DOI] [PubMed] [Google Scholar]
- SMITH H., GALLOP R. C., HARRIS-SMITH P. W., STANLEY J. L. The virulence-enhancing factor of mucins. VI. Identification of a heparin as the main component of the third factor involved in virulence enhancement. Biochem J. 1952 Sep;52(1):23–29. doi: 10.1042/bj0520023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SMITH H., GALLOP R. C., STANLEY J. L. The virulence-enhancing factor of mucins. V. The different components of the third factor involved in virulence enhancement. Biochem J. 1952 Sep;52(1):15–22. doi: 10.1042/bj0520015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SMITH H., GALLOP R. C. The acid polysaccharides of hog gastric mucosa. Biochem J. 1953 Mar;53(4):666–671. doi: 10.1042/bj0530666. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SMITH H., HARRIS-SMITH P. W., STANLEY J. L., PETO S. The virulence-enhancing factor of mucins. IV. The role of particulate insoluble matter and a viscous medium in virulence enhancement, with a revised assay of the third factor involved. Biochem J. 1951 Dec;50(2):211–216. doi: 10.1042/bj0500211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SMITH H. The virulence-enhancing factor of mucins. 3. further fractionation of hog gastric mucin; an additional factor in the adjuvant action. Biochem J. 1951 Apr;48(4):441–447. doi: 10.1042/bj0480441. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SMITH H., ZWARTOUW H. T., GALLOP R. C., HARRIS-SMITH P. W. The virulence-enhancing factor of mucins. 7. The remaining components of the third factor involved in virulence enhancement. Biochem J. 1953 Mar;53(4):673–678. doi: 10.1042/bj0530673. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith H. The virulence-enhancing factor of mucins. 1. A biological assay of virulence-enhancing activity. Biochem J. 1950 Mar;46(3):352–356. doi: 10.1042/bj0460352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith H. The virulence-enhancing factor of mucins. 2. Fractionation studies on hog gastric mucin. Biochem J. 1950 Mar;46(3):356–363. doi: 10.1042/bj0460356. [DOI] [PMC free article] [PubMed] [Google Scholar]
